Title : Multicenter phase II study of second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study.

Pub. Date : 2014 Apr

PMID : 24692733






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Multicenter phase II study of second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study. FOLFIRI regimen KRAS proto-oncogene, GTPase Homo sapiens